Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England
Despite recent advances in first-line therapies for multiple myeloma (MM), most patients relapse or become refractory, underscoring the need for effective second-line (2L) regimens for relapsed/refractory MM (RRMM). This study describes the real-world baseline characteristics, treatment patterns and...
Gespeichert in:
Veröffentlicht in: | EJHaem 2025-02, Vol.6 (1), p.e1058 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!